Gov't Contractor Indicted For Alleged $116M Drug Return Plot
A company tasked with returning expired drugs for health care providers and the U.S. government stole $116 million worth of refunds from pharmaceutical manufacturers and then obstructed a subsequent investigation into...To view the full article, register now.
Already a subscriber? Click here to view full article